Mortality and employment after in-patient opiate detoxification
A. Naderi-Heiden a 
, A. Gleiss b, C. Bäcker a, D. Bieber a, H. Nassan-Agha a, S. Kasper a, R. Frey a
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L'accès au texte intégral de ce chapitre nécessite l'achat du livre ou l'achat du chapitre.
| pages | 7 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Abstract
Aim
We considered that completed opiate detoxification resulted in increased life expectancy and earning capacity as compared to non-completed detoxification.
Methods
The cohort study sample included pure opioid or poly-substance addicts admitted for voluntary in-patient detoxification between 1997 and 2004. Of 404 patients, 58.7% completed the detoxification program and 41.3% did not. The Austrian Social Security Institution supplied data on survival and employment records for every single day in the individual observation period between discharge and December 2007. Statistical analyses included the calculation of standardized mortality rates for the follow-up period of up to 11 years.
Results
The standardized mortality ratios (SMRs) were between 13.5 and 17.9 during the first five years after discharge, thereafter they fell clearly with time. Mortality did not differ statistically significantly between completers and non-completers. The median employment rate was insignificantly higher in completers (12.0%) than in non-completers (5.5%). The odds for being employed were higher in pure opioid addicts than in poly-substance addicts (p=0.003).
Conclusions
The assumption that completers of detoxification treatment have a better outcome than non-completers has not been confirmed. The decrease in mortality with time elapsed since detoxification is interesting. Pure opioid addicts had better employment prospects than poly-substance addicts.
Keywords : Mortality, Employment, Opiate detoxification, Opioid dependence, Poly-substance dependence
Plan
Vol 27 - N° 4
P. 294-300 - mai 2012 Retour au numéro
Article précédent
- Handedness, repetitive transcranial magnetic stimulation and bulimic disorders
- F. Van den Eynde, H. Broadbent, S. Guillaume, A. Claudino, I.C. Campbell, U. Schmidt
- Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice
- J. Bobes, G. Rubio, A. Terán, G. Cervera, V. López-Gómez, I. Vilardaga, M. Pérez
Bienvenue sur EM-consulte,
la référence des professionnels de santé.
Plus de 500 000 articles médicaux,
paramédicaux et scientifiques vous attendent.
L'accès au texte intégral de cet article nécessite un abonnement ou un achat à l'unité.
Déjà abonné à cette revue ?